Avalo Therapeutics (AVTX)
(Delayed Data from NSDQ)
$11.83 USD
-0.05 (-0.42%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $11.48 -0.35 (-2.96%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Avalo Therapeutics, Inc. has a market cap of $156.25M, which represents its share price of $11.88 multiplied by its outstanding shares number of 13.15M. As a small-cap company, AVTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
AVTX 11.83 -0.05(-0.42%)
Will AVTX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AVTX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for AVTX
Is AVTX preparing to trend higher? MACD Bullish Signal Line Cross shows up after slipping 0.42%
AVTX forms Pocket Pivot on September 19
Crossed Above 20 Day Moving Average appears for AVTX after 16.09% move
Oppenheimer Reaffirms Their Buy Rating on Avalo Therapeutics (AVTX)
AVTX: HC Wainwright & Co. Raises Price Target and Maintains Buy Rating | AVTX Stock News